Bausch Health Companies Inc. Other Noncash Income (Expense)
Bausch Health Companies Inc. (BHC) reported Other Noncash Income (Expense) of $1.00 million for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-11-02.
Discontinued › Cash Flow › Operating Activities
us-gaap:OtherNoncashIncomeExpense · last filed 2023-11-02
- Bausch Health Companies Inc. other noncash income (expense) for the quarter ending 2023-09-30 was $7.00M, a 53.33% decline year-over-year.
- Bausch Health Companies Inc. other noncash income (expense) for the quarter ending 2023-06-30 was -$10.00M, a 266.67% decline year-over-year.
- Bausch Health Companies Inc. other noncash income (expense) for the quarter ending 2023-03-31 was $4.00M.
- Bausch Health Companies Inc. other noncash income (expense) for the quarter ending 2022-09-30 was $15.00M, a 66.67% increase year-over-year.
- Bausch Health Companies Inc. other noncash income (expense) for fiscal 2017 was $22.00M.
- Bausch Health Companies Inc. other noncash income (expense) for fiscal 2016 was -$26.00M.
- Bausch Health Companies Inc. other noncash income (expense) for fiscal 2014 was -$32.00M, a 942.11% decline from fiscal 2013.
- Bausch Health Companies Inc. other noncash income (expense) for fiscal 2013 was $3.80M, a 72.06% decline from fiscal 2012.
| Period end | Other Noncash Income (Expense) 3 month | Other Noncash Income (Expense) 3 month as first filed | Other Noncash Income (Expense) 6 month | Other Noncash Income (Expense) 6 month as first filed | Other Noncash Income (Expense) 9 month | Other Noncash Income (Expense) 9 month as first filed | Other Noncash Income (Expense) 12 month | Other Noncash Income (Expense) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2023-09-30 | $7.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | -$3.00M derived: sum of 2 quarters · filed 2023-11-02 | $1.00M 10-Q · filed 2023-11-02 | |||||
| 2023-06-30 | -$10.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | -$6.00M 10-Q · filed 2023-08-03 | ||||||
| 2023-03-31 | $4.00M 10-Q · filed 2023-05-04 | |||||||
| 2022-09-30 | $15.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $21.00M derived: sum of 2 quarters · filed 2023-11-02 | $11.00M 10-Q · filed 2023-11-02 | $19.00M derived: sum of 4 quarters · filed 2023-11-02 | ||||
| 2022-06-30 | $6.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | -$4.00M 10-Q · filed 2023-08-03 | $4.00M derived: sum of 3 quarters · filed 2023-08-03 | $13.00M derived: sum of 4 quarters · filed 2023-08-03 | ||||
| 2022-03-31 | -$10.00M 10-Q · filed 2023-05-04 | -$2.00M derived: sum of 2 quarters · filed 2023-05-04 | $7.00M derived: sum of 3 quarters · filed 2023-05-04 | $13.00M derived: sum of 4 quarters · filed 2023-05-04 | ||||
| 2021-12-31 | $8.00M derived: 8-K 12 month − 10-Q 9 month · filed 2022-05-11 | $17.00M derived: sum of 2 quarters · filed 2022-11-03 | $23.00M derived: sum of 3 quarters · filed 2022-11-03 | $41.00M 8-K · filed 2022-05-11 | ||||
| 2021-09-30 | $9.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $15.00M derived: sum of 2 quarters · filed 2022-11-03 | $33.00M 10-Q · filed 2022-11-03 | $44.00M derived: sum of 4 quarters · filed 2022-11-03 | ||||
| 2021-06-30 | $6.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $24.00M 10-Q · filed 2022-08-09 | $35.00M derived: sum of 3 quarters · filed 2022-08-09 | $33.00M derived: sum of 4 quarters · filed 2022-08-09 | ||||
| 2021-03-31 | $18.00M 10-Q · filed 2022-05-10 | $29.00M derived: sum of 2 quarters · filed 2022-05-11 | $27.00M derived: sum of 3 quarters · filed 2022-05-11 | $29.00M derived: sum of 4 quarters · filed 2022-05-11 | ||||
| 2020-12-31 | $11.00M derived: 8-K 12 month − 10-Q 9 month · filed 2022-05-11 | $9.00M derived: sum of 2 quarters · filed 2022-05-11 | $11.00M derived: sum of 3 quarters · filed 2022-05-11 | $18.00M 8-K · filed 2022-05-11 | ||||
| 2020-09-30 | -$2.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02 | $0.00 derived: sum of 2 quarters · filed 2021-11-02 | $7.00M 10-Q · filed 2021-11-02 | $1.00M derived: sum of 4 quarters · filed 2022-05-11 | ||||
| 2020-06-30 | $2.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-03 | $9.00M 10-Q · filed 2021-08-03 | $3.00M derived: sum of 3 quarters · filed 2022-05-11 | -$11.00M derived: sum of 4 quarters · filed 2022-05-11 | ||||
| 2020-03-31 | $7.00M 10-Q · filed 2021-05-04 | $1.00M derived: sum of 2 quarters · filed 2022-05-11 | -$13.00M derived: sum of 3 quarters · filed 2022-05-11 | -$20.00M derived: sum of 4 quarters · filed 2022-05-11 | ||||
| 2019-12-31 | -$6.00M derived: 8-K 12 month − 10-Q 9 month · filed 2022-05-11 | -$20.00M derived: sum of 2 quarters · filed 2022-05-11 | -$27.00M derived: sum of 3 quarters · filed 2022-05-11 | -$36.00M 8-K · filed 2022-05-11 | ||||
| 2019-09-30 | -$14.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-03 | -$21.00M derived: sum of 2 quarters · filed 2020-11-03 | -$30.00M 10-Q · filed 2020-11-03 | -$27.00M 10-Q · filed 2019-11-04 | -$32.00M derived: sum of 4 quarters · filed 2021-05-04 | |||
| 2019-06-30 | -$7.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | -$16.00M 10-Q · filed 2020-08-06 | -$18.00M derived: sum of 3 quarters · filed 2021-05-04 | -$1.00M derived: sum of 4 quarters · filed 2021-05-04 | ||||
| 2019-03-31 | -$9.00M 10-Q · filed 2020-05-07 | -$11.00M derived: sum of 2 quarters · filed 2021-05-04 | $6.00M derived: sum of 3 quarters · filed 2021-05-04 | $5.00M derived: sum of 4 quarters · filed 2021-05-04 | ||||
| 2018-12-31 | -$2.00M derived: 8-K 12 month − 10-Q 9 month · filed 2021-05-04 | $15.00M derived: sum of 2 quarters · filed 2021-05-04 | $14.00M derived: sum of 3 quarters · filed 2021-05-04 | $17.00M 8-K · filed 2021-05-04 | ||||
| 2018-09-30 | $17.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-04 | $16.00M derived: sum of 2 quarters · filed 2019-11-04 | $19.00M 10-Q · filed 2019-11-04 | $17.00M derived: sum of 4 quarters · filed 2020-02-19 | ||||
| 2018-06-30 | -$1.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $2.00M 10-Q · filed 2019-08-06 | $0.00 derived: sum of 3 quarters · filed 2020-02-19 | $22.00M derived: sum of 4 quarters · filed 2020-02-19 | ||||
| 2018-03-31 | $3.00M 10-Q · filed 2019-05-06 | $1.00M derived: sum of 2 quarters · filed 2020-02-19 | $23.00M derived: sum of 3 quarters · filed 2020-02-19 | $23.00M derived: sum of 4 quarters · filed 2020-02-19 | ||||
| 2017-12-31 | -$2.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-19 | $20.00M derived: sum of 2 quarters · filed 2020-02-19 | $20.00M derived: sum of 3 quarters · filed 2020-02-19 | $22.00M 10-K · filed 2020-02-19 | $26.00M 10-K · filed 2018-02-28 | |||
| 2017-09-30 | $22.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | $22.00M derived: sum of 2 quarters · filed 2018-11-06 | $24.00M 10-Q · filed 2018-11-06 | -$14.00M derived: sum of 4 quarters · filed 2019-02-20 | ||||
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | $2.00M 10-Q · filed 2018-08-07 | -$36.00M derived: sum of 3 quarters · filed 2019-02-20 | -$33.00M derived: sum of 4 quarters · filed 2019-02-20 | ||||
| 2017-03-31 | $2.00M 10-Q · filed 2018-05-08 | $1.00M 10-Q · filed 2017-05-09 | -$36.00M derived: sum of 2 quarters · filed 2019-02-20 | -$33.00M derived: sum of 3 quarters · filed 2019-02-20 | -$25.00M derived: sum of 4 quarters · filed 2019-02-20 | |||
| 2016-12-31 | -$38.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-20 | -$35.00M derived: sum of 2 quarters · filed 2019-02-20 | -$27.00M derived: sum of 3 quarters · filed 2019-02-20 | -$26.00M 10-K · filed 2019-02-20 | -$8.00M 10-K · filed 2017-03-01 | |||
| 2016-09-30 | $3.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $11.00M derived: sum of 2 quarters · filed 2017-11-07 | $12.00M 10-Q · filed 2017-11-07 | $12.20M 10-Q · filed 2016-11-09 | $31.40M derived: sum of 4 quarters · filed 2018-08-10 | |||
| 2016-06-30 | $8.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | $9.00M 10-Q · filed 2017-08-08 | $9.50M 10-Q · filed 2016-08-09 | $28.40M derived: sum of 3 quarters · filed 2018-08-10 | $28.20M derived: sum of 4 quarters · filed 2018-08-10 | |||
| 2016-03-31 | $1.00M 10-Q · filed 2017-05-09 | -$1.90M 10-Q · filed 2016-06-07 | $20.40M derived: sum of 2 quarters · filed 2018-08-10 | $20.20M derived: sum of 3 quarters · filed 2018-08-10 | $22.90M derived: sum of 4 quarters · filed 2018-08-10 | |||
| 2015-12-31 | $19.40M derived: 8-K 12 month − 10-Q 9 month · filed 2018-08-10 | $19.20M derived: sum of 2 quarters · filed 2018-08-10 | $21.90M derived: sum of 3 quarters · filed 2018-08-10 | $33.00M 8-K · filed 2018-08-10 | $11.20M 10-K · filed 2016-04-29 | |||
| 2015-09-30 | -$200.00K 10-Q · filed 2015-10-26 | $2.50M derived: sum of 2 quarters · filed 2015-10-26 | $13.60M 10-Q · filed 2016-11-09 | $13.70M 10-Q · filed 2015-10-26 | -$6.50M derived: sum of 4 quarters · filed 2017-03-01 | |||
| 2015-06-30 | $2.70M 10-Q · filed 2015-07-28 | $9.90M 10-Q · filed 2016-08-09 | -$6.30M derived: sum of 3 quarters · filed 2017-03-01 | -$16.00M derived: sum of 4 quarters · filed 2017-03-01 | ||||
| 2015-03-31 | $7.20M 10-Q · filed 2016-06-07 | -$9.00M derived: sum of 2 quarters · filed 2017-03-01 | -$18.70M derived: sum of 3 quarters · filed 2017-03-01 | -$15.00M derived: sum of 4 quarters · filed 2017-03-01 | ||||
| 2014-12-31 | -$16.20M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | -$25.90M derived: sum of 2 quarters · filed 2017-03-01 | -$22.20M derived: sum of 3 quarters · filed 2017-03-01 | -$32.00M 10-K · filed 2017-03-01 | -$32.30M 10-K · filed 2015-02-25 | |||
| 2014-09-30 | -$9.70M 10-Q · filed 2015-10-26 | -$6.00M derived: sum of 2 quarters · filed 2015-10-26 | -$15.80M 10-Q · filed 2015-10-26 | -$25.40M derived: sum of 4 quarters · filed 2016-04-29 | ||||
| 2014-06-30 | $3.70M 10-Q · filed 2015-07-28 | -$6.10M 10-Q · filed 2015-07-28 | -$15.70M derived: sum of 3 quarters · filed 2016-04-29 | -$10.80M derived: sum of 4 quarters · filed 2016-04-29 | ||||
| 2014-03-31 | -$9.70M 10-Q · filed 2015-04-30 | -$19.40M derived: sum of 2 quarters · filed 2016-04-29 | -$14.50M derived: sum of 3 quarters · filed 2016-04-29 | -$6.80M derived: sum of 4 quarters · filed 2016-04-29 | ||||
| 2013-12-31 | -$9.70M derived: 10-K 12 month − 10-Q 9 month · filed 2016-04-29 | -$4.80M derived: sum of 2 quarters · filed 2016-04-29 | $2.90M derived: sum of 3 quarters · filed 2016-04-29 | $3.80M 10-K · filed 2016-04-29 | -$466.00K 10-K · filed 2014-02-28 | |||
| 2013-09-30 | $4.90M 10-Q · filed 2014-10-24 | $4.78M 10-Q · filed 2013-11-01 | $12.60M derived: sum of 2 quarters · filed 2014-10-24 | $13.50M 10-Q · filed 2014-10-24 | $7.42M 10-Q · filed 2013-11-01 | $14.36M derived: sum of 4 quarters · filed 2015-02-25 | ||
| 2013-06-30 | $7.70M 10-Q · filed 2014-08-01 | $3.61M 10-Q · filed 2013-08-07 | $8.60M 10-Q · filed 2014-08-01 | $2.64M 10-Q · filed 2013-08-07 | $9.46M derived: sum of 3 quarters · filed 2015-02-25 | $17.33M derived: sum of 4 quarters · filed 2015-02-25 | ||
| 2013-03-31 | $3.70M 10-Q · filed 2014-05-09 | -$965.00K 10-Q · filed 2013-05-03 | $1.76M derived: sum of 2 quarters · filed 2015-02-25 | $9.63M derived: sum of 3 quarters · filed 2015-02-25 | $9.69M derived: sum of 4 quarters · filed 2015-02-25 | |||
| 2012-12-31 | -$1.94M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-25 | $5.93M derived: sum of 2 quarters · filed 2015-02-25 | $5.99M derived: sum of 3 quarters · filed 2015-02-25 | $13.60M 10-K · filed 2015-02-25 | $15.67M 10-K · filed 2013-02-28 | |||
| 2012-09-30 | $7.87M 10-Q · filed 2013-11-01 | $5.54M 10-Q · filed 2012-11-05 | $7.93M derived: sum of 2 quarters · filed 2013-11-01 | $15.54M 10-Q · filed 2013-11-01 | $15.11M 10-Q · filed 2012-11-05 | $42.50M derived: sum of 4 quarters · filed 2014-02-28 | ||
| 2012-06-30 | $60.00K 10-Q · filed 2013-08-07 | $25.00K 10-Q · filed 2012-08-03 | $7.67M 10-Q · filed 2013-08-07 | $9.56M 10-Q · filed 2012-08-03 | $34.63M derived: sum of 3 quarters · filed 2014-02-28 | $43.80M derived: sum of 4 quarters · filed 2014-02-28 | ||
| 2012-03-31 | $7.61M 10-Q · filed 2013-05-03 | $1.05M 10-Q · filed 2012-05-04 | $34.57M derived: sum of 2 quarters · filed 2014-02-28 | $43.74M derived: sum of 3 quarters · filed 2014-02-28 | $31.12M derived: sum of 4 quarters · filed 2014-02-28 | |||
| 2011-12-31 | $26.96M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-28 | $36.13M derived: sum of 2 quarters · filed 2014-02-28 | $23.51M derived: sum of 3 quarters · filed 2014-02-28 | $18.42M 10-K · filed 2014-02-28 | -$4.15M 10-K · filed 2012-02-29 | |||
| 2011-09-30 | $9.17M 10-Q · filed 2012-11-05 | $7.74M 10-Q · filed 2011-11-04 | -$3.45M derived: sum of 2 quarters · filed 2012-11-05 | -$8.54M 10-Q · filed 2012-11-05 | $755.00K 10-Q · filed 2011-11-04 | -$9.77M derived: sum of 4 quarters · filed 2013-02-28 | ||
| 2011-06-30 | -$12.62M 10-Q · filed 2012-08-03 | -$6.26M 10-Q · filed 2011-08-08 | -$17.71M 10-Q · filed 2012-08-03 | -$6.98M 10-Q · filed 2011-08-08 | -$18.94M derived: sum of 3 quarters · filed 2013-02-28 | -$24.00M derived: sum of 4 quarters · filed 2013-02-28 | ||
| 2011-03-31 | -$4.22M 10-Q · filed 2012-05-04 | -$6.32M derived: sum of 2 quarters · filed 2013-02-28 | -$11.37M derived: sum of 3 quarters · filed 2013-02-28 | -$11.61M derived: sum of 4 quarters · filed 2013-02-28 | ||||
| 2010-12-31 | -$2.09M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-28 | -$7.15M derived: sum of 2 quarters · filed 2013-02-28 | -$7.39M derived: sum of 3 quarters · filed 2013-02-28 | -$7.02M 10-K · filed 2013-02-28 | $1.20M 10-K · filed 2012-02-29 | |||
| 2010-09-30 | -$5.06M 10-Q · filed 2011-11-04 | -$5.30M derived: sum of 2 quarters · filed 2011-11-04 | -$4.93M 10-Q · filed 2011-11-04 | |||||
| 2010-06-30 | -$238.00K 10-Q · filed 2011-08-08 | $129.00K 10-Q · filed 2011-08-08 | ||||||
| 2009-12-31 | $177.00K 10-K · filed 2012-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| OCULAR THERAPEUTIX, INC (OCUL) | United States | $2.159B | -7.15 |
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 |